1. Home
  2. MIRM vs LTH Comparison

MIRM vs LTH Comparison

Compare MIRM & LTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$75.65

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Logo Life Time Group Holdings Inc.

LTH

Life Time Group Holdings Inc.

HOLD

Current Price

$27.74

Market Cap

5.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
LTH
Founded
2018
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
5.7B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
MIRM
LTH
Price
$75.65
$27.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
10
Target Price
$92.45
$38.65
AVG Volume (30 Days)
870.1K
1.8M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.46
EPS
N/A
1.28
Revenue
$471,794,000.00
$2,913,442,000.00
Revenue This Year
$53.78
$15.07
Revenue Next Year
$19.91
$10.94
P/E Ratio
N/A
$21.60
Revenue Growth
53.66
15.77
52 Week Low
$36.88
$22.71
52 Week High
$82.58
$34.99

Technical Indicators

Market Signals
Indicator
MIRM
LTH
Relative Strength Index (RSI) 55.24 64.05
Support Level $73.82 $25.60
Resistance Level $82.58 $27.16
Average True Range (ATR) 3.41 0.64
MACD 0.12 0.11
Stochastic Oscillator 67.09 75.46

Price Performance

Historical Comparison
MIRM
LTH

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About LTH Life Time Group Holdings Inc.

Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.

Share on Social Networks: